nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A belated diagnosis of G6PD deficiency in an 81-year-old woman
|
Tran Quang, Violaine |
|
|
100 |
7 |
p. 1901-1902 |
artikel |
2 |
Aberrant myelomonocytic CD56 expression in Down syndrome is frequent and not associated with leukemogenesis
|
Gadgeel, Manisha |
|
|
100 |
7 |
p. 1695-1700 |
artikel |
3 |
A novel Twist1/hsa-miR138-5p/caspase-3 pathway regulates cell proliferation and apoptosis of human multiple myeloma
|
Qin, Wenjiao |
|
|
100 |
7 |
p. 1815-1824 |
artikel |
4 |
Characteristics and survival trends in Finnish multiple myeloma patients—a nationwide real-world evidence study
|
Toppila, Iiro |
|
|
100 |
7 |
p. 1779-1787 |
artikel |
5 |
Chronic active Epstein-Barr virus infection of T cell type presenting with hemophagocytic lymphohistiocytosis in a Caucasian adult
|
Jiang, Debbie |
|
|
100 |
7 |
p. 1899-1900 |
artikel |
6 |
Clinical characteristics and therapeutic outcomes of paroxysmal nocturnal hemoglobinuria patients in Turkey: a multicenter experience
|
Goren Sahin, Deniz |
|
|
100 |
7 |
p. 1667-1675 |
artikel |
7 |
Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice—data from a Belgian registry
|
Devos, Timothy |
|
|
100 |
7 |
p. 1723-1732 |
artikel |
8 |
Comparative study of IgG binding to megakaryocytes in immune and myelodysplastic thrombocytopenic patients
|
Elzaeem, Doaa I. |
|
|
100 |
7 |
p. 1701-1709 |
artikel |
9 |
Complete regression of an HCV-associated diffuse large B cell lymphoma achieved by chemoimmuno-free antiviral therapy
|
Sun, Xiao-Hong |
|
|
100 |
7 |
p. 1891-1894 |
artikel |
10 |
Correction to: Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial
|
Heuser, Michael |
|
|
100 |
7 |
p. 1917-1918 |
artikel |
11 |
Correction to: High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin lymphoma
|
Swoboda, Ryszard |
|
|
100 |
7 |
p. 1919 |
artikel |
12 |
Does the order of busulfan and cyclophosphamide affect allogeneic stem cell transplantation related liver toxicity?
|
Kidoguchi, Keisuke |
|
|
100 |
7 |
p. 1911-1912 |
artikel |
13 |
Gastrointestinal toxicity of high-dose melphalan in autologous hematopoietic stem cell transplantation: identification of risk factors and a benchmark for experimental therapies
|
Gordillo, Christian A. |
|
|
100 |
7 |
p. 1863-1870 |
artikel |
14 |
Hepatocellular carcinoma in patients with thalassemia in the post-DAA era: not a disappearing entity
|
Ricchi, Paolo |
|
|
100 |
7 |
p. 1907-1910 |
artikel |
15 |
HHV-6 encephalitis in a non-transplanted adult acute myeloid leukemia patient
|
Voigt, Margarete |
|
|
100 |
7 |
p. 1895-1897 |
artikel |
16 |
High efficacy of BGD (bendamustine, gemcitabine, and dexamethasone) in relapsed/refractory Hodgkin Lymphoma
|
Swoboda, Ryszard |
|
|
100 |
7 |
p. 1755-1767 |
artikel |
17 |
Impact of anti-thymocyte globulin dose for graft-versus-host disease prophylaxis in allogeneic hematopoietic cell transplantation from matched unrelated donors: a multicenter experience
|
Butera, Sara |
|
|
100 |
7 |
p. 1837-1847 |
artikel |
18 |
Incidence and impact of Epstein-Barr virus events in the early phase after allogeneic hematopoietic cell transplantation
|
Macy, Samuel |
|
|
100 |
7 |
p. 1913-1915 |
artikel |
19 |
Magnesium levels and outcome after allogeneic hematopoietic stem cell transplantation in acute myeloid leukemia
|
Angenendt, Linus |
|
|
100 |
7 |
p. 1871-1878 |
artikel |
20 |
Monitoring treatment with 5-Azacitidine by flow cytometry predicts duration of hematological response in patients with myelodysplastic syndrome
|
Subirá, Dolores |
|
|
100 |
7 |
p. 1711-1722 |
artikel |
21 |
Oral therapy adherence and satisfaction in patients with multiple myeloma
|
Solano, Marine |
|
|
100 |
7 |
p. 1803-1813 |
artikel |
22 |
Pleural effusion-based nomogram to predict outcomes in unselected patients with multiple myeloma: a large single center experience
|
Hou, Zi-Liang |
|
|
100 |
7 |
p. 1789-1801 |
artikel |
23 |
Pretreatment with ibrutinib reduces cytokine secretion and limits the risk of obinutuzumab-induced infusion-related reactions in patients with CLL: analysis from the iLLUMINATE study
|
Greil, Richard |
|
|
100 |
7 |
p. 1733-1742 |
artikel |
24 |
Severe homocysteinemia in two givosiran-treated porphyria patients: is free heme deficiency the culprit?
|
Petrides, Petro E. |
|
|
100 |
7 |
p. 1685-1693 |
artikel |
25 |
Single cord blood transplantation for acute myeloid leukemia patients aged 60 years or older: a retrospective study in Japan
|
Isobe, Masamichi |
|
|
100 |
7 |
p. 1849-1861 |
artikel |
26 |
Survival and treatment patterns of patients with relapsed or refractory multiple myeloma in France — a cohort study using the French National Healthcare database (SNDS)
|
Touzeau, Cyrille |
|
|
100 |
7 |
p. 1825-1836 |
artikel |
27 |
The rare hemoglobin variant Hb Mizuho: report of a Swiss family and literature review
|
Njue, Linet |
|
|
100 |
7 |
p. 1677-1683 |
artikel |
28 |
The role of ponatinib in adult BCR-ABL1 positive acute lymphoblastic leukemia after allogeneic transplantation: a real-life retrospective multicenter study
|
Leotta, Salvatore |
|
|
100 |
7 |
p. 1743-1753 |
artikel |
29 |
The time-dependent effects of early-onset Epstein-Barr viremia on adult acute leukemia patients following allo-HSCT with ATG-containing MAC regimen
|
Ke, Peng |
|
|
100 |
7 |
p. 1879-1889 |
artikel |
30 |
Thrombocytosis in children and adolescents—classification, diagnostic approach, and clinical management
|
Stockklausner, Clemens |
|
|
100 |
7 |
p. 1647-1665 |
artikel |
31 |
Treatment patterns and outcomes in real-world transplant-ineligible patients newly diagnosed with multiple myeloma
|
Cejalvo, María José |
|
|
100 |
7 |
p. 1769-1778 |
artikel |
32 |
Variations in hemoglobin level and morbidity burden in non-transfusion-dependent β-thalassemia
|
Musallam, Khaled M. |
|
|
100 |
7 |
p. 1903-1905 |
artikel |